Daily Dose - Sep 28th, 2026
Daily Dose |
View online
September 28, 2026
Manufacturing of new FDA-approved drugs moving to China: GlobalData
The share of newer FDA-approved innovator and biosimilar products whose production mix included a Chinese facility is rising, says data and analytics firm.
Read More
Vetter plans new commercial fill-finish lines across several global sites
The expansion includes seven lines at existing locations and three planned for a new commercial facility in Saarlouis, Germany.
Read More
CordenPharma breaks ground on $200M peptide expansion in South Carolina
The North Augusta project will add 68,000 square feet of commercial manufacturing space and expand upstream peptide synthesis capacity.
Read More